- Home
- IAE vs RPTX Comparison
IAE vs RPTX Comparison
Compare IAE & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IAE
- RPTX
- Stock Information
- Founded
- IAE 2007
- RPTX 2016
- Country
- IAE United States
- RPTX Canada
- Employees
- IAE N/A
- RPTX N/A
- Industry
- IAE Trusts Except Educational Religious and Charitable
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- IAE Finance
- RPTX Health Care
- Exchange
- IAE Nasdaq
- RPTX Nasdaq
- Market Cap
- IAE 78.6M
- RPTX 78.2M
- IPO Year
- IAE N/A
- RPTX 2020
- Fundamental
- Price
- IAE $7.26
- RPTX $2.17
- Analyst Decision
- IAE
- RPTX Strong Buy
- Analyst Count
- IAE 0
- RPTX 3
- Target Price
- IAE N/A
- RPTX $3.50
- AVG Volume (30 Days)
- IAE 46.3K
- RPTX 752.3K
- Earning Date
- IAE 01-01-0001
- RPTX 11-14-2025
- Dividend Yield
- IAE 10.21%
- RPTX N/A
- EPS Growth
- IAE N/A
- RPTX N/A
- EPS
- IAE N/A
- RPTX N/A
- Revenue
- IAE N/A
- RPTX $11,870,000.00
- Revenue This Year
- IAE N/A
- RPTX N/A
- Revenue Next Year
- IAE N/A
- RPTX N/A
- P/E Ratio
- IAE N/A
- RPTX N/A
- Revenue Growth
- IAE N/A
- RPTX N/A
- 52 Week Low
- IAE $5.31
- RPTX $0.89
- 52 Week High
- IAE $6.45
- RPTX $4.07
- Technical
- Relative Strength Index (RSI)
- IAE 37.92
- RPTX 68.07
- Support Level
- IAE $7.21
- RPTX $1.65
- Resistance Level
- IAE $7.52
- RPTX $2.30
- Average True Range (ATR)
- IAE 0.13
- RPTX 0.09
- MACD
- IAE -0.04
- RPTX 0.05
- Stochastic Oscillator
- IAE 9.19
- RPTX 77.69
About IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.